The need of a continuous productivity increases in medicinal chemistry laboratories of the pharmaceutical industry motivated the development, over the years, of new software solutions to enable Open-Access in many analytical techniques such as NMR or LC, among others, to characterize and assess the purity of new molecules. These approaches have bee...
Siddiqui, Farid A.Parkkola, HannaManoharan, Ganesh BabuAbankwa, Daniel
The protein-folding chaperone Hsp90 enables the maturation and stability of various oncogenic signaling proteins and is thus pursued as a cancer drug target. Folding in particular of protein kinases is assisted by the co-chaperone Cdc37. Several inhibitors against the Hsp90 ATP-binding site have been developed. However, they displayed significant t...
Peyronie's disease (PD) is a debilitating affliction for the male population, causing severe curvatures to the erect penis and erectile dysfunction in about 50% of men. This deviation of the penis significantly impairs sexual intercourse and causes depression and strains in the relationship. As of today, medical treatment options are few and far be...
The Botnar Foundation (grant number: 6063), the Cystic Fibrosis Trust (Strategic Research Centre Awards 002, 010 & 201) and the Bill and Melinda Gates Foundation, Shorten-TB Award.
Clare, Rachel HBardelle, CatherineHarper, PaulHong, W DavidBörjesson, UlfJohnston, Kelly LCollier, MatthewMyhill, LauraCassidy, AndrewPlant, Darren
...
The early stages of drug discovery is a long and costly process. A way to reduce the time, resources, and financial investment spent is to apply computational tools. With the tremendous progress and achievements in computational chemistry, the application of computational tools in the drug lead discovery and design has increased. Today, computation...
